Loading…

Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review

The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibil...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics 2023-04, Vol.15 (4), p.1306
Main Authors: Jîtcă, Carmen-Maria, Jîtcă, George, Ősz, Bianca-Eugenia, Pușcaș, Amalia, Imre, Silvia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53
container_end_page
container_issue 4
container_start_page 1306
container_title Pharmaceutics
container_volume 15
creator Jîtcă, Carmen-Maria
Jîtcă, George
Ősz, Bianca-Eugenia
Pușcaș, Amalia
Imre, Silvia
description The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.
doi_str_mv 10.3390/pharmaceutics15041306
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A747471679</galeid><doaj_id>oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c</doaj_id><sourcerecordid>A747471679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</originalsourceid><addsrcrecordid>eNptUl1v0zAUjRCITWM_AWSJB3jpsOM4iXlBVWEwqWIVg2frJrnuXCVxZydF_fe7XUe1ovk82Lo-51zdjyR5K_iFlJp_Wt9C6KDGcXB1FIpnQvL8RXIqtNaTTKfy5ZP3SXIe44rTkVKUUr9OTmQhhCi0OE3GmwEq17phy7xl1wFaNnd3o2vYVx9hiezShy4y17MFNg6G4Go2g9A43_rl9jObskXAgKSIbkBmfWALGBz2w4fIbsDisJ1M2U8IgaIbZL9w4_Dvm-SVhTbi-eN9lvy5_PZ79mMyv_5-NZvOJ7VKxTCREhqQmbaaV6lGrsGWBCjTlJe2yq0WokxzLJRKdakrq5sUBKYlgCYoeZZc7X0bDyuzDq6DsDUenHkI-LA0EKiHLZqcZxklsVxamYFSWkubq0rppqhqW9bk9WXvtR6rDpuaSqRuHZke__Tu1iz9xgguspTsyeHjo0PwdyPGwXQu1ti20KMfo0lLTjPROc-J-v4_6sqPoade7Vi5KrimmR9YS6AKXG89Ja53pmZaZASRF5pYF8-wCA12rvY9WkfxI4HaC-rgYwxoD0UKbnb7Z57dP9K9e9qhg-rftsl7HozY8Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2806570941</pqid></control><display><type>article</type><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</creator><creatorcontrib>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</creatorcontrib><description>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</description><identifier>ISSN: 1999-4923</identifier><identifier>EISSN: 1999-4923</identifier><identifier>DOI: 10.3390/pharmaceutics15041306</identifier><identifier>PMID: 37111791</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Cardiology ; Dosage and administration ; dosage form ; Drug dosages ; Drug stability ; Evaluation ; FDA approval ; Federal regulation ; Good Manufacturing Practice ; oral liquid ; Oral medication ; pediatric ; Pediatric cardiology ; Pediatrics ; Pharmaceutical industry ; Review ; Safety and security measures ; stability</subject><ispartof>Pharmaceutics, 2023-04, Vol.15 (4), p.1306</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</cites><orcidid>0000-0001-8187-126X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2806570941/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2806570941?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37111791$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jîtcă, Carmen-Maria</creatorcontrib><creatorcontrib>Jîtcă, George</creatorcontrib><creatorcontrib>Ősz, Bianca-Eugenia</creatorcontrib><creatorcontrib>Pușcaș, Amalia</creatorcontrib><creatorcontrib>Imre, Silvia</creatorcontrib><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><title>Pharmaceutics</title><addtitle>Pharmaceutics</addtitle><description>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</description><subject>Age</subject><subject>Cardiology</subject><subject>Dosage and administration</subject><subject>dosage form</subject><subject>Drug dosages</subject><subject>Drug stability</subject><subject>Evaluation</subject><subject>FDA approval</subject><subject>Federal regulation</subject><subject>Good Manufacturing Practice</subject><subject>oral liquid</subject><subject>Oral medication</subject><subject>pediatric</subject><subject>Pediatric cardiology</subject><subject>Pediatrics</subject><subject>Pharmaceutical industry</subject><subject>Review</subject><subject>Safety and security measures</subject><subject>stability</subject><issn>1999-4923</issn><issn>1999-4923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl1v0zAUjRCITWM_AWSJB3jpsOM4iXlBVWEwqWIVg2frJrnuXCVxZydF_fe7XUe1ovk82Lo-51zdjyR5K_iFlJp_Wt9C6KDGcXB1FIpnQvL8RXIqtNaTTKfy5ZP3SXIe44rTkVKUUr9OTmQhhCi0OE3GmwEq17phy7xl1wFaNnd3o2vYVx9hiezShy4y17MFNg6G4Go2g9A43_rl9jObskXAgKSIbkBmfWALGBz2w4fIbsDisJ1M2U8IgaIbZL9w4_Dvm-SVhTbi-eN9lvy5_PZ79mMyv_5-NZvOJ7VKxTCREhqQmbaaV6lGrsGWBCjTlJe2yq0WokxzLJRKdakrq5sUBKYlgCYoeZZc7X0bDyuzDq6DsDUenHkI-LA0EKiHLZqcZxklsVxamYFSWkubq0rppqhqW9bk9WXvtR6rDpuaSqRuHZke__Tu1iz9xgguspTsyeHjo0PwdyPGwXQu1ti20KMfo0lLTjPROc-J-v4_6sqPoade7Vi5KrimmR9YS6AKXG89Ja53pmZaZASRF5pYF8-wCA12rvY9WkfxI4HaC-rgYwxoD0UKbnb7Z57dP9K9e9qhg-rftsl7HozY8Q</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Jîtcă, Carmen-Maria</creator><creator>Jîtcă, George</creator><creator>Ősz, Bianca-Eugenia</creator><creator>Pușcaș, Amalia</creator><creator>Imre, Silvia</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8187-126X</orcidid></search><sort><creationdate>20230401</creationdate><title>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</title><author>Jîtcă, Carmen-Maria ; Jîtcă, George ; Ősz, Bianca-Eugenia ; Pușcaș, Amalia ; Imre, Silvia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age</topic><topic>Cardiology</topic><topic>Dosage and administration</topic><topic>dosage form</topic><topic>Drug dosages</topic><topic>Drug stability</topic><topic>Evaluation</topic><topic>FDA approval</topic><topic>Federal regulation</topic><topic>Good Manufacturing Practice</topic><topic>oral liquid</topic><topic>Oral medication</topic><topic>pediatric</topic><topic>Pediatric cardiology</topic><topic>Pediatrics</topic><topic>Pharmaceutical industry</topic><topic>Review</topic><topic>Safety and security measures</topic><topic>stability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jîtcă, Carmen-Maria</creatorcontrib><creatorcontrib>Jîtcă, George</creatorcontrib><creatorcontrib>Ősz, Bianca-Eugenia</creatorcontrib><creatorcontrib>Pușcaș, Amalia</creatorcontrib><creatorcontrib>Imre, Silvia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jîtcă, Carmen-Maria</au><au>Jîtcă, George</au><au>Ősz, Bianca-Eugenia</au><au>Pușcaș, Amalia</au><au>Imre, Silvia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review</atitle><jtitle>Pharmaceutics</jtitle><addtitle>Pharmaceutics</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>1306</spage><pages>1306-</pages><issn>1999-4923</issn><eissn>1999-4923</eissn><abstract>The development of safe and effective pediatric formulations is essential, especially in therapeutic areas such as pediatric cardiology, where the treatment requires multiple dosing or outpatient care. Although liquid oral dosage forms are considered the formulation of choice given the dose flexibility and acceptability, the compounding practices are not endorsed by the health authorities, and achieving stability can be problematic. The purpose of this study is to provide a comprehensive overview of the stability of liquid oral dosage forms used in pediatric cardiology. An extensive review of the literature has been performed, with a particular focus on cardiovascular pharmacotherapy, by consulting the current studies indexed in PubMed, ScienceDirect, PLoS One, and Google Scholar databases. Regulations and guidelines have been considered against the studies found in the literature. Overall, the stability study is well-designed, and the critical quality attributes (CQAs) have been selected for testing. Several approaches have been identified as innovative in order to optimize stability, but opportunities to improve have been also identified, such as in-use studies and achieving dose standardization. Consequently, the information gathering and the results of the studies can be translated into clinical practice in order to achieve the desired stability of liquid oral dosage forms.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37111791</pmid><doi>10.3390/pharmaceutics15041306</doi><orcidid>https://orcid.org/0000-0001-8187-126X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1999-4923
ispartof Pharmaceutics, 2023-04, Vol.15 (4), p.1306
issn 1999-4923
1999-4923
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6044b29f03f34a55993f65b59d7bcf8c
source Publicly Available Content Database; PubMed Central
subjects Age
Cardiology
Dosage and administration
dosage form
Drug dosages
Drug stability
Evaluation
FDA approval
Federal regulation
Good Manufacturing Practice
oral liquid
Oral medication
pediatric
Pediatric cardiology
Pediatrics
Pharmaceutical industry
Review
Safety and security measures
stability
title Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient's Safety-A Narrative Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A27%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stability%20of%20Oral%20Liquid%20Dosage%20Forms%20in%20Pediatric%20Cardiology:%20A%20Prerequisite%20for%20Patient's%20Safety-A%20Narrative%20Review&rft.jtitle=Pharmaceutics&rft.au=J%C3%AEtc%C4%83,%20Carmen-Maria&rft.date=2023-04-01&rft.volume=15&rft.issue=4&rft.spage=1306&rft.pages=1306-&rft.issn=1999-4923&rft.eissn=1999-4923&rft_id=info:doi/10.3390/pharmaceutics15041306&rft_dat=%3Cgale_doaj_%3EA747471679%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c521t-33ada349f90b29e09af8f8fa82208fb6f911826e7552989bf9d2a1e28aa9a9a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2806570941&rft_id=info:pmid/37111791&rft_galeid=A747471679&rfr_iscdi=true